Submit Deal

ABOLIS BIOTECHNOLOGIES

HQ - Evry

Summary

Abolis Biotechnologies is a company specializing in industrial solutions using microorganisms.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 30 M

Avg. Deal Size£ 30 M

Market Context

Senior Management

Sort

Target: ABOLIS BIOTECHNOLOGIES

Bidder: EVONIK VENTURE CAPITAL

10 Service Providers

12 Dealmakers

£ 29 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy